Clinical Trial Update: Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma [Phase 3]

View source ↗

Summary

Phase 3 study evaluating bronchospasm potential of a next-generation propellant versus HFA propellant in an inhaler for adults with well- or partially controlle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2025-07-30